30/01/2019

Ovarian Cancer Drug Approved For Use In NI

An ovarian cancer drug with the potential to extend the life of patients has been approved for use in Northern Ireland for the first time.

Women will now be able to use niraparib, which is already available through the NHS in England, Scotland and Wales.

An average of 221 cases are diagnosed each year in Northern Ireland, and those with recurring ovarian cancer can make use of the drug.

Niraparib works as a targeted treatment which exploits specific weaknesses in cancer cells, preventing them from repairing themselves.

The drug is expected to improve the quality of life for women suffering from the condition, and will lengthen the time when it is stable and not progressing.

Implementing the recommendations of NICE (the National Institute for Health and Care Excellence), the Department of Health has brought patients in the region in line with those from the rest of the UK.

SDLP Health Spokesperson Mark Durkan welcomed the approval of the life-extending treatment.

"For many years the SDLP have stood shoulder to shoulder with sufferers of cancer and other conditions fighting for fair access to vital medication- for parity with elsewhere in the UK," he explained.
News Image
"Access to cancer drugs such as Niraparib should not be based on cost but rather on patient need. I am hopeful this medication can help ease the suffering and improve the lives of many people here, including providing their loved ones with comfort in the knowledge that they are being treated with the most suitable drug for their needs.

"Whilst today's announcement is welcome, it is long overdue. Today we think of all those who campaigned for this civil right and those who would have benefited from it but sadly were not given that chance."

The Foyle MLA continued to call for the restoration of Stormont's power-sharing institutions to ensure the public get change on issues of importance.

"Frustratingly, access to Niraparib and other critical drugs have been delayed in the absence of a Health Minister and a functioning Assembly. As too has the urgent need for the implementation of a cancer strategy. These are the issues we need to get serious on, these are the reasons we need our Executive back up and running. People suffering from cancer cannot afford to wait- the people of Northern Ireland deserve better than to be treated as second class citizens where health is concerned."



(JG/CM)

Related Northern Ireland News Stories
Click here for the latest headlines.

10 April 2014
Stormont Group Says More Cancer Could Be Prevented
Almost 12,800 people in Northern Ireland are diagnosed with cancer each year and a significant number of these could be prevented through greater awareness, a new report from the All Party Group on Cancer (APGC) at Stormont has revealed.
09 November 2006
Consultation launched on cancer control
A public consultation has been launched on a new Cancer Control Programme for Northern Ireland. The report aims to deliver improvements in the delivery of cancer services and outcomes for patients.
09 September 2011
Yellowhammer Portraits Are Framing Success
Two local cancer charities, the Ulster Cancer Foundation (UCF) and Friends of the Cancer Centre, have announced a unique fundraising initiative - the opportunity to buy a highly collectable piece of art by acclaimed Irish artist, Nicola Russell, while making a significant contribution to the work of both charities.
07 November 2008
UCF Targets Cancer Awareness
The signs and symptoms of Northern Ireland's biggest cancer killer are being highlighted by a local charity this week with the Ulster Cancer Foundation (UCF) using national 'Lung Cancer Awareness Month' as a springboard to target local people.
07 April 2004
Health meeting to tackle cancer scourge
Northern Ireland's Chief Medical Officer today met with leading figures from the American Cancer Society to discuss how cancer prevention, treatment and research could be benefited from greater collaboration. Dr Henrietta Campbell said today's meeting was one of the significant benefits arising from the American/All-Ireland Cancer Consortium.